NYSCF in the News

NYSCF-Robertson Neuroscience Investigator Dr. Winrich Freiwald, The Rockefeller University, published his latest paper understanding how mammals make sense of faces in PLoS Biology. Faces convey an abundance of social information and Dr. Freiwald’s paper, for this first time, makes sense of how this information is exchanged between different brain regions. Brain areas that process facial information pass information to regions of the brain associated with social cognition.  The research takes advantage of fMRI technology, which reveals brain activity by measuring changes in blood flow in the brain. Freiwald’s lab showed that areas of the brain associated with facial recognition are embedded in a larger brain network, which connects facial recognition to structures that support emotive, memory, and cognitive functions.


Read the paper in PLoS Biology >>

NYSCF – Robertson Investigator Dr. Feng Zhang pioneered technology to edit DNA. The system he created, CRISPR/Cas9, means scientists can now study disease, cures, and cellular functions by quickly and easily manipulating genes.  Dr. Zhang, The Broad Institute of Harvard and MIT and The McGovern Institute for Brain Research at MIT, published a paper in Science that investigates engineering the genome editing protein, Cas9. While the CRISPR system has proved revolutionary for scientists to study our cells, researchers have struggled with its ability to edit unintended stretches of DNA, preventing clinical application. In engineering Cas9, Dr. Zhang’s lab created a protein that reduces “off-target” effects of this breakthrough technology that lifts the entire field of biomedical research.


Read the paper in Science >>

Read more in The Atlantic >>

Read more in Stat >>

Read more in Nature News >>

(Photo: Len Rubenstein, courtesy of Broad Institute Communications)

NYSCF – Robertson Neuroscience Investigator Dr. Ed Boyden, MIT, received a Breakthrough Prize, an award of $3 million, and was celebrated like a star at the Breakthrough Prize ceremony in California. The Breakthrough Prize, established by Internet pioneers such as Sergey Brin of Google, Mark Zuckerberg of Facebook and Jack Ma of Alibaba, was designed to recognize scientists like the celebrities they are.  

Dr. Boyden’s work is seminal in neuroscience. His research gives scientists the tools to zoom in on brain functions, isolating and studying different neurons and their interactions. In developing optogenics, he created a system that allows researchers to control neurons with light, revolutionizing neuroscientists’ capacity to understand the brain.    


Read about the Breakthrough Prize in The New York Times 

NYSCF – Robertson Investigator Dr. Alexander Meissner, Broad Institute of MIT and Harvard, along with NYSCF – Robertson Investigator Dr. Gabsang Lee, John Hopkins University, explored the features of induced pluripotent stem, iPS, cells as compared to embryonic stem cells. They showed that stem cells from embryos, and stem cells from adult cells transformed into ‘embryonic-like’ cells are functionally and molecularly the same. This is a concern that has plagued the field since iPS cells were first generated in 2007. They published their innovative research in Nature Biotechnology where they compared embryonic stem cells and iPS cells from the same donor and found no significant differences in these cells that have the power to mature into any type of cell in the human body, a concept termed ‘pluripotentcy.’

Appearing in the same issue of Nature Biotechnology, Dr. Meissner’s research team also published a study on a new method developed to characterize the pluripotency of stem cells. Their method quantifies the expression of genes involved in cell pluripotency. The “ScoreCard” created by the research team can also be utilized to characterize a variety of cells, molecules, and conditions cells live in. Both pieces of research supported by NYSCF push the scientific community toward a better understanding of stem cells so that research can best harness their power to create cures. 


Read the first paper in Nature Biotechnology 

Read the second paper in Nature Biotechnology 

As NYSCF – Robertson Investigator Feng Zhang, Broad Institute of Harvard and MIT, explained at The NYSCF Conference, “Nature is smarter than us.” Dr. Zhang’s lab works to discover bacterial proteins that can cut DNA at targeted sites in order to create a toolbox of proteins that can edit DNA. Previously, Dr. Zhang pioneered the CRISPR-Cas system which uses RNA that can interact with DNA to guide Cas proteins to specific sites to cut DNA, effectively altering the genome. 
In Dr. Zhang’s latest work published in Cell, his laboratory shows another protein, Cpf1, can cleave DNA, and that proteins similar to Cpf1 may also have this capacity. He followed up this publication with a study in Molecular Cell that identifies other proteins that function distinctly from previously identified proteins which can be guided to edit target DNA.  
This work expands research’s repertoire of tools to harness, understand and overcome nature. CRISPR gene editing systems are currently in use toward understanding genes and disease, and are also studied for their therapeutic potential.

Read the Molecular Cell paper >>


Read more about Dr. Zhang’s work:

The New Yorker

STAT News 

The New York Times

NYSCF - Robertson Neuroscience Investigator Dr. Paola Arlotta, Harvard Stem Cell Institute and the Broad Institute of Harvard and MIT, showed that neuronal networks of communication between reprogrammed neurons and the surrounding cells can be changed. Essentially, that the neighboring cells of reprogrammed neurons recognize that they are changed, and therefore change how they communicate with the 'new' cells. This work, published in Neuron, builds on Dr. Arlotta's previous finding that neurons can be reprogrammed into different neuronal types in the brains of live animals, a result that upended traditional neurobiology dogma.

This research has vast implications on understanding how neural communication works and builds circuits in early development as well as how this communication frays and deteriorates in neurodegenerative and psychiatric diseases such as autism and schizophrenia.


Read more in the Harvard Gazette >>

Read the paper in Neuron >>

Wednesday, 21 October 2015 00:00

NYSCF Celebrates 10th Year at Annual Gala

This October, NYSCF honored Stephen M. Ross, Jack and Jeff Gernsheimer, and Mark McCauley as stem cell heroes at the 10th Anniversary Gala. Held at Skylight at Moynihan Station, the annual Gala brought together NYSCF friends, scientists, and supporters to celebrate the past 10 years of success and to look forward to the next ten years and beyond.

Wednesday, 07 October 2015 12:24

Stem Cells in Clinical Trials to Cure Blindness

In 2011 NYSCF awarded Dr. Pete Coffey the inaugural NYSCF–Robertson Stem Cell Prize for his pioneering work bringing stem cell therapies to patients with macular degeneration. Now patients in the UK can begin to realize the promises of regenerative medicine as treatments move into the clinic. Dr. Pete Coffey co-leads The London Project to Cure Blindness, which, with NYSCF support, has begun to translate stem cell research into cures. Announced in September, the first patient received treatment for ‘wet’ age-related macular degeneration. The researchers behind the clinical trial used stem cells to create a patch of eye cells, retinal pigment epithelium, to transplant into patients with diseased retinal pigment epithelium. Thus far, the patient remains healthy boding well for this clinical trial to confirm safety and efficacy.


Read more about The London Project >>

Learn more about The NYSCF–Robertson Prize >>

Page 8 of 31
You are here: News NYSCF in the News